The medication is still activating GLP-1 receptors, still slowing gastric emptying, still modulating appetite circuits
A question I often get from patients is whether they can use both at the same time, and the answer is yes
The first mechanism involves the enhancement of the reloading of the insulin pool available for immediate release, occurring only in the presence of incretin and at a certain glucose threshold
doi.org/10.1056/NEJMoa2301972 Coskun, T., et al
The complex was subjected to size-exclusion chromatography (SEC) on a Superose 6 Increase 10/300 column (GE Healthcare) equilibrated with 20 mM HEPES pH 7.5, 100 mM NaCl, 2 mM MgCl 2 , 1 M semaglutide, 0.01% (w/v) LMNG, and 0.006% (w/v) CHS